产品详情
Targets
Target | Value |
---|---|
RET | IC50: 1.5nM |
Raf-1 | IC50: 2.5nM |
VEGFR2 | IC50: 4.2nM |
Kit | IC50: 7nM |
VEGFR1 | IC50: 13nM |
B-Raf(V600E) | IC50: 19nM |
PDGFRβ | IC50: 22nM |
B-Raf | IC50: 28nM |
VEGFR3 | IC50: 46nM |
FGFR1 | IC50: 202nM |
Tie-2 | IC50: 311nM |
In vitro (25°C) | DMSO | 88 mg/mL (182.26 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 2% DMSO+30% PEG 300+5% Tween 80+ddH2O | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.71 mL | 103.56 mL | 207.13 mL |
0.5 mM | 4.14 mL | 20.71 mL | 41.43 mL |
1 mM | 2.07 mL | 10.36 mL | 20.71 mL |
5 mM | 0.41 mL | 2.07 mL | 4.14 mL |
*The above data is based on the productmolecular weight 482.8. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10250 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 482.8 |
Formula | C21H15ClF4N4O3 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 755037-03-7 |
SMILES | CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F |
产品资料
产品标签
Product Questions
Product Questions
Bibf1120 (Nintedanib)
Bibf1120 (Nintedanib)是一种新型的三联血管激酶抑制剂,可同时抑制三种生长因子受体:VEGFR,PDGF和FGFR。
Apatinib (YN968D1)
Apatinib (YN968D1)是一种酪氨酸激酶抑制剂,可选择性抑制血管内皮生长因子受体2(VEGFR2,也称为KDR),后者…
Vandetanib (ZD6474)
Vandetanib (ZD6474)是一种VEGFR和EGFR拮抗剂,是一种酪氨酸激酶抑制剂,对于HUVEC增殖,PC-9细胞和酪氨酸激酶活…
Crenolanib (CP-868596)
Crenolanib (CP-868596)是口服生物可用的PDGFR酪氨酸激酶的选择性小分子抑制剂,在皮摩尔浓度下抑制PDGFRA和PDGFR…